Skip to main content
Gufic BioSciences Ltd. logo

Gufic BioSciences Ltd. — Investor Relations & Filings

Ticker · GUFICBIO ISIN · INE742B01025 LEI · 3358003C6YDH6EIDBP63 BSE.NS Manufacturing
Open in API
Filings indexed 1,189 across all filing types
Latest filing 2026-05-22 Board/Management Inform…
Country IN India
Listing BSE.NS GUFICBIO

About Gufic BioSciences Ltd.

https://gufic.com/

Gufic BioSciences Ltd. focuses on the research, development, and large-scale manufacturing of pharmaceutical formulations and active pharmaceutical ingredients. The organization is distinguished by its specialized expertise in lyophilization technology, operating extensive facilities for the production of freeze-dried injectables. Its product portfolio encompasses a wide range of therapeutic areas, including critical care, infertility, oncology, and gastroenterology. In addition to conventional medicine, the company develops proprietary herbal and ayurvedic formulations through integrated scientific research. Gufic emphasizes advanced drug delivery systems and maintains a significant presence in the production of antibiotics, antifungal agents, and cardiac medications. The company serves a global clientele by providing high-quality generic and specialty healthcare solutions.

Recent filings

Filing Released Lang Actions
Gufic Biosciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2026 ,inter alia, to consider and approve Audited Financial Results ....
Board/Management Information Classification · 92% confidence The document is a formal intimation under SEBI Listing Regulations informing stock exchanges of a scheduled Board of Directors meeting to consider approving audited financial results and recommending a dividend. It is not the meeting materials or AGM materials themselves, nor is it a financial report. This type of announcement—scheduling a board meeting—is classified as Board/Management Information (MANG).
2026-05-22 English
Update on further investment in Selvax Pty Ltd. is attached herewith
Regulatory Filings
2026-04-29 English
General Updates
Regulatory Filings
2026-04-29 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a detailed communication addressed to stock exchanges regarding a newspaper advertisement about a special window for re-lodgement of transfer and dematerialization of physical shares. It references compliance with SEBI regulations and includes a copy of the advertisement published in a newspaper. The content is primarily an announcement of an event or action taken by the company rather than a financial report or detailed analysis. There are no financial statements, management discussions, or earnings data present. The document length is about 15,000 characters, but the content is focused on regulatory compliance and shareholder communication via advertisement. This fits best with the category of Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit into more specific categories.
2026-04-15 English
Newspaper Advertisement regarding Special Window for Re-lodgement of Transfer and Dematerialization of physical shares is attached herewith
Regulatory Filings
2026-04-15 English
Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended March 31, 2026 is attached herewith
Regulatory Filings
2026-04-07 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.